Medlab is an Australian biotechnology company (ASX:MDC) that is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas including pain management, mental health, gut health, diabetes, and allergies.